Close

Immunovant Announces Closing of $139.4 Million Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Apr 16, 2020 04:01PM
Immunovant (IMVT) Announces Pricing of $121.2 Million Public Offering of Common Stock Apr 14, 2020 09:28AM
Immunovant Announces Pricing of $121.2 Million Public Offering Apr 14, 2020 09:28AM